New York, Jan 21, 2026, 05:40 EST — Premarket
- Aditxt shares were up about 25% in premarket trading after closing up 36% on Tuesday
- Traders are looking ahead to a Jan. 30 shareholder meeting with votes tied to Nasdaq rules, a name change and a possible reverse split
- Nasdaq compliance remains in focus after a December notice tied to stockholders’ equity
Aditxt Inc shares rose about 25% in premarket trading on Wednesday after the microcap healthcare company closed up 35.6% in the previous session. The stock last traded around $1.47 premarket after finishing Tuesday at $1.18, with roughly 35 million shares changing hands in the regular session. (StockAnalysis)
The burst of trading puts a spotlight back on a company with a market value of about $2 million, where small flows can whip prices around. Next week’s shareholder vote and lingering Nasdaq compliance questions are also hanging over the stock. (StockAnalysis)
In a Dec. 16 proxy statement, Aditxt set a Jan. 30 special meeting for holders to vote on a slate of proposals, including approvals required under Nasdaq Marketplace Rule 5635(d) tied to earlier preferred stock and warrant financings. Shareholders will also be asked to approve an employee stock purchase plan, expand the share pool under its 2021 equity plan to 350,000 shares from 3, take a non-binding vote on changing the company’s name to “bitXbio, Inc.” and authorize a potential reverse stock split in a range of 1-for-5 to 1-for-250. (SEC)
Rule 5635(d) is one of Nasdaq’s guardrails on discounted stock deals. In plain terms, it can require shareholder approval before a company issues stock (or stock-linked securities) that could amount to 20% or more of shares outstanding at a price below recent trading levels.
Aditxt is also dealing with a separate Nasdaq notice tied to stockholders’ equity — a balance-sheet measure of assets minus liabilities. In a Dec. 5 filing, the company said Nasdaq told it the equity level reported in its Sept. 30 quarterly report did not meet the exchange’s minimum, and it had until Jan. 15 to submit a plan to regain compliance; Nasdaq could grant an extension to May 30 if it accepts the plan. (SEC)
Tuesday’s trading was outsized even by small-cap standards. The roughly 35 million shares traded were about 80 times Aditxt’s 20-day average volume of roughly 431,000 shares, data compiled by Stock Analysis showed. (StockAnalysis)
The proxy materials lay out a familiar playbook for companies trying to hold onto a listing: more flexibility to issue stock and another potential reverse split. A reverse stock split bundles existing shares into fewer shares, typically to push the per-share price higher, though it does not change the company’s value on its own.
But the setup carries risk for existing holders. If shareholders approve the proposals, Aditxt could be able to issue more shares tied to preferred stock conversions and warrant exercises, which can dilute existing investors, and reverse splits sometimes draw selling once they take effect.
The stock’s next test is concrete. Investors will be watching the Jan. 30 vote and any fresh update from Nasdaq on whether Aditxt’s compliance plan is accepted — and, after that, whether the company can show progress ahead of the May 30 deadline flagged in its filing.
